Toshihiro Mita Selected Research

artemisinin (artemisinine)

4/2024	Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance.
1/2023	The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
1/2022	Circulation of an Artemisinin-Resistant Malaria Lineage in a Traveler Returning from East Africa to France.
1/2022	Evidence of Artemisinin-Resistant Malaria in Africa. Reply.
4/2021	Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
1/2021	Evidence of Artemisinin-Resistant Malaria in Africa.
12/2020	Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea.
1/2018	Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016.
1/2016	Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites.
1/2016	Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiro Mita Research Topics

Disease

32	Malaria 05/2024 - 06/2010
7	Falciparum Malaria (Plasmodium falciparum Malaria) 04/2024 - 04/2003
4	Infections 01/2022 - 06/2016
2	Communicable Diseases (Infectious Diseases) 06/2022 - 06/2016
1	Parasitemia 01/2023
1	Measles 06/2022
1	Rubella (German Measles) 06/2022
1	Dysbiosis 02/2022
1	Ulcerative Colitis 02/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Amebiasis (Amoebiasis) 01/2022
1	Hepatitis 01/2022
1	Amebic Liver Abscess 01/2022
1	Neoplasms (Cancer) 01/2022
1	Parasitic Diseases (Parasitic Disease) 01/2022
1	Chagas Disease (American Trypanosomiasis) 12/2016
1	Hypoxia (Hypoxemia) 04/2016
1	Vivax Malaria 06/2011

Drug/Important Bio-Agent (IBA)

15	artemisinin (artemisinine)IBA 04/2024 - 06/2010
5	VaccinesIBA 06/2015 - 06/2011
4	Chloroquine (Aralen)FDA LinkGeneric 02/2020 - 04/2003
3	Pyrimethamine (Daraprim)FDA Link 05/2024 - 06/2010
3	Malaria VaccinesIBA 01/2023 - 02/2012
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2012
2	pyrimethamine drug combination fanasil (Fansidar)FDA Link 05/2024 - 11/2006
2	Antimalarials (Antimalarial Agents)IBA 04/2024 - 06/2022
2	Immunoglobulin G (IgG)IBA 06/2022 - 01/2022
2	ArtesunateIBA 01/2022 - 01/2021
2	Lumefantrine FDA Link 02/2020 - 11/2018
2	2,3,6-trichloroindophenolIBA 12/2016 - 06/2016
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2016 - 08/2014
2	AntigensIBA 06/2015 - 02/2013
1	Histidine (L-Histidine)FDA Link 04/2022
1	AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Sulfadoxine (Sulformethoxine)FDA Link 10/2021
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 04/2021
1	piperaquineIBA 01/2021
1	Messenger RNA (mRNA)IBA 06/2016
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 06/2016
1	MyoglobinIBA 04/2016
1	MetmyoglobinIBA 04/2016
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	NAD (NADH)IBA 04/2016
1	Adenylosuccinate LyaseIBA 06/2015
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 06/2015
1	Genetic Markers (Genetic Marker)IBA 06/2015
1	Merozoite Surface Protein 1 (MSA1)IBA 06/2015
1	N 30IBA 06/2015
1	Folic Acid AntagonistsIBA 01/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2011

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2010
1	Chemoprevention 05/2024
1	Aftercare (After-Treatment) 01/2023
1	Fecal Microbiota Transplantation 02/2022
1	Donor Selection 02/2022
1	Diagnostic Equipment 01/2020